Literature DB >> 9251221

Thermal-death times of opaque and translucent morphotypes of Vibrio vulnificus.

C M Kim1, K C Jeong, J H Rhee, S H Choi.   

Abstract

Thermal-death times were determined for Vibrio vulnificus strains with different morphotypes. Opaque strains showed higher D values (times required to reduce the viable population of a given strain by 90%) than translucent strains. Z values (absolute values of the temperature required to reduce 1 log scale of D values) were also significantly higher in opaque morphotypes (2.4 to 2.5 degrees C) than in translucent ones (1.7 to 2.1 degrees C). These results indicate that the morphotype is related to the organism's susceptibility to heat.

Entities:  

Mesh：

Year:  1997        PMID： 9251221      PMCID： PMC168632          DOI： 10.1128/aem.63.8.3308-3310.1997

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN： 0099-2240            Impact factor:   4.792


  9 in total

1.  Correlation between virulence and colony morphology in Vibrio vulnificus.

Authors:  L M Simpson; V K White; S F Zane; J D Oliver
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

2.  The cytolysin gene of Vibrio vulnificus: sequence and relationship to the Vibrio cholerae E1 Tor hemolysin gene.

Authors:  K Yamamoto; A C Wright; J B Kaper; J G Morris
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  Effects of Physicochemical Factors and Bacterial Colony Morphotype on Association of Vibrio vulnificus with Hemocytes of Crassostrea virginica.

Authors:  L Harris-Young; M L Tamplin; W S Fisher; J W Mason
Journal:  Appl Environ Microbiol       Date:  1993-04       Impact factor: 4.792

4.  Relation of capsular materials and colony opacity to virulence of Vibrio vulnificus.

Authors:  S Yoshida; M Ogawa; Y Mizuguchi
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

5.  Pyruvate production and excretion by the luminous marine bacteria.

Authors:  E G Ruby; K H Nealson
Journal:  Appl Environ Microbiol       Date:  1977-08       Impact factor: 4.792

6.  Vibrio vulnificus septicemia in Korea: clinical and epidemiologic findings in seventy patients.

Authors:  S D Park; H S Shon; N J Joh
Journal:  J Am Acad Dermatol       Date:  1991-03       Impact factor: 11.527

7.  Purification and determination of the structure of capsular polysaccharide of Vibrio vulnificus M06-24.

Authors:  G P Reddy; U Hayat; C Abeygunawardana; C Fox; A C Wright; D R Maneval; C A Bush; J G Morris
Journal:  J Bacteriol       Date:  1992-04       Impact factor: 3.490

8.  Phenotypic evaluation of acapsular transposon mutants of Vibrio vulnificus.

Authors:  A C Wright; L M Simpson; J D Oliver; J G Morris
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

9.  Presence of a capsule in Vibrio vulnificus biotype 2 and its relationship to virulence for eels.

Authors:  E G Biosca; H Llorens; E Garay; C Amaro
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441
  9 in total
  4 in total

1.  High-frequency phase variation of Vibrio vulnificus 1003: isolation and characterization of a rugose phenotypic variant.

Authors:  Brenda L Grau; Margaret C Henk; Gregg S Pettis
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

2.  Direct identification of Vibrio vulnificus in clinical specimens by nested PCR.

Authors:  S E Lee; S Y Kim; S J Kim; H S Kim; J H Shin; S H Choi; S S Chung; J H Rhee
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

3.  Characterization of Vibrio fluvialis-like strains implicated in limp lobster disease.

Authors:  B D Tall; S Fall; M R Pereira; M Ramos-Valle; S K Curtis; M H Kothary; D M T Chu; S R Monday; L Kornegay; T Donkar; D Prince; R L Thunberg; K A Shangraw; D E Hanes; F M Khambaty; K A Lampel; J W Bier; R C Bayer
Journal:  Appl Environ Microbiol       Date:  2003-12       Impact factor: 4.792

Review 4.  Structure, Function, and Regulation of the Essential Virulence Factor Capsular Polysaccharide of Vibrio vulnificus.

Authors:  Gregg S Pettis; Aheli S Mukerji
Journal:  Int J Mol Sci       Date:  2020-05-05       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.